Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
-119.60%
↓ 117% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineDecelerating
Average
-55.18%
Historical baseline
PeriodValue
2024-119.60%
2023-43.79%
2022-57.32%
20210.00%